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Abstract
Background: A significant and independent association between testosterone levels and
coronary events in men and women has not been confirmed in large prospective studies,
although some reports have shown that endogenous testosterone concentrations in men are
inversely related to cardiovascular and general mortality.
Methods: We aimed to assess the relationship between serum testosterone level and short-
-time (30-day) mortality in men with acute myocardial infarction.
Results: We included 126 consecutive male patients admitted with acute myocardial infarc-
tion. The mean age was 62 ± 13 years. We determined, at admission, serum free testosterone
(T) level (using a chemoluminiscence assay), high sensitivity C-reactive protein, N-terminal pro-
-B-type natriuretic peptide, and glycated hemoglobin level. We analyzed the 30-day mortality.
Conclusions: The mean level of serum T was 4.1 ± 2.9 ng/mL. All non-survivors had T level
£ 3 ng/mL. A low level of T was independently related to total short-term mortality. (Cardiol J
2010; 17, 3: 249–253)
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Introduction
A significant and independent association between
endogenous testosterone (T) levels and coronary
events in men and women has not been confirmed in
large prospective studies. There is some data suggest-
ing that coronary artery disease is associated with low
T level in men. Hypoandrogenemia was shown to be
associated with visceral obesity, insulin resistance, low
high-density lipoprotein (HDL) cholesterol and elevat-
ed triglycerides, low-density lipoprotein (LDL) choles-
terol, and plasminogen activator type 1.
The effects of exogenous T on cardiovascular
mortality or morbidity have not been extensively
investigated in prospective controlled studies.
Some data suggests there may be beneficial effects
in men with coronary artery disease.
In animal experiments, exogenous testoster-
one had neutral or beneficial effects on the athero-
sclerosis process. Exogenous androgens decrease
serum levels of HDL-cholesterol, plasminogen ac-
tivator type 1, lipoprotein (a), fibrinogen, insulin,
leptin, and visceral fat mass.
Exogenous testosterone, in high concentra-
tions, produces vasodilation; at physiological con-
centrations, there are mixed effects on vascular
reactivity.
250




We included 126 consecutive male patients
admitted to the Craiova Cardiology Center between
January and December 2008 with a diagnosis of
acute myocardial infarction (MI), established based
on current guidelines of the European Society of
Cardiology.
Patients were excluded if they had been cas-
trated as treatment for testicular or prostate can-
cer or if they were taking any medications known
to affect sex hormone concentrations (e.g. antian-
drogenic agents for prostate cancer). Approval for
the study was obtained from the local Research
Ethics Committee, and informed consent was ob-
tained from all participants.
All patients/patient’s family were contacted by
phone  30 days after admission. The mortality data
was based on the charts of the hospital or on infor-
mation provided by the patient’s family.
Evaluation
We determined, at admission, serum free tes-
tosterone level, high sensitivity C-reactive protein
(hsCRP), N-terminal pro-B-type natriuretic peptide
(NT-proBNP), glycemia and glycated hemoglobin
level, total cholesterol, HDL-cholesterol, LDL-choles-
terol and triglycerides. The blood sample was obtained
at approximately the same hour in the morning.
Testosterone level was measured using
a chemoluminiscence assay. Serum level of NT-
-proBNP was determined at admission using a com-
mercially available assay device with a measuring
range between 60–3,000 pg/mL.
A standard transthoracic echocardiography
exam was performed in the 48 hours following ad-
mission; left ventricular ejection fraction (LVEF) was
measured using the modified Simpson method.
Statistical analysis
Statistical analyses were performed  using
SPSS 15.0 for Windows. Student’s t test was used
to analyze differences between mean values, and
ANOVA was used to analyze differences between
multiple groups. Pearson’s correlation coefficient
was calculated to determine associations between
continuous variables. A probability value of  0.05 or
less was considered significant.
Results
The mean age of the patients included was 62 ±
± 13 years.
Due to the relatively small number of patients, we
decided to divide the group in relation to the type of
myocardial infarction, into an ST segment elevation
MI group and a non-ST segment elevation MI group.
The characteristics of the patients and the va-
lues (mean ± standard deviation) of the laboratory
measurements are presented in Table 1.
The total 30 day mortality was 12.69% (16 pa-
tients). Based on the available medical data (hospi-
tal charts, death certificates), and on other informa-
tion related to the mode of death, 12 patients died
of cardiovascular causes and four of non-cardiovas-
cular causes (including those with not witnessed
sudden death).
The characteristics of survivors and non-sur-
vivors (mean ± standard deviation) and the statis-
tical significance of the differences between the two
groups are presented in Table 2.
The non-survivors were predominantly in the
group of non-ST segment elevation MI (68.8% vs
51.3%, p < 0.01), and had a higher proportion of
previously diagnosed diabetes mellitus (32.7% vs
37.5%, p = 0.043).
They had significantly lower HDL-cholesterol
levels; hsCRP and NT-proBNP, which are known
risk markers for cardiovascular mortality, were
higher in non-survivors.
All non-survivors in our population had T le-
vel £ 3 ng/mL, and the mean value was significantly
lower than in patients who survived (2.1 ± 0.8 vs
4.3 ± 3.3, p < 0.01).
Table 1. Patient characterisics.
Age (years) 61.7 ± 12.9
ST segment elevation MI (%) 41.2
Arterial hypertension (%) 68.2
Diabetes mellitus (%) 33.3
Smokers (%) 65.8
Body mass index [kg/m2] 26.7 ± 7.8
Baseline glycemia [mg/dL] 114.7 ± 41.7
Total cholesterol [mg/dL] 190.4 ± 50.5
Triglycerides [mg/dL] 183.0 ± 79.1
HDL [mg/dL] 41.8 ± 14.8
LDL [mg/dL] 118.3 ± 38.0
hsCRP [mg/L] 31.8 ± 25.4
Glycated hemoglobin (%) 6.3 ± 0.8
NT-proBNP [pg/mL] 1827.0 ± 983.1
Tesosterone [ng/mL] 4.1 ± 2.9
LVEF (%) 35.4 ± 10.6
MI — myocardial infarction; HDL — high-density lipoprotein chole-
sterol; LDL — low-density lipoprotein cholesterol; hsCRP — high
sensitivity C-reactive protein; NT-proBNP — N-terminal pro-B-type
natriuretic peptide; LVEF — left ventricular ejection fraction
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Table 3 shows the distribution of variables
by quartile group of serum testosterone level.
Testosterone concentrations were significantly
inversely related to body mass index, triglyceri-
des, prevalence of diabetes mellitus, and hsCRP,
and were positively related to total cholesterol,
LDL cholesterol, and HDL cholesterol concen-
trations.
Table 4 shows the odds ratio for all-cause mor-
tality adjusted for age and the other covariates. Age-
-adjusted odds ratio for mortality due to all causes
decreased significantly with increasing quartile
Table 2. Characteristics of survivors and non-survivors.
Survivors Non-survivors p
Age (years) 60.1 ± 12.1 64.4 ± 9.2 NS
ST segment elevation MI (%) 42.7 31.2 < 0.01
Arterial hypertension (%) 68.1 68.7 NS
Diabetes mellitus (%) 32.7 37.5 0.043
Smokers (%) 66.3 62.5 NS
Body mass index [kg/m2] 26.4 ± 5.6 27.3 ± 4.3 NS
Baseline glycemia [mg/dL] 113.9 ± 53.1 116.4 ± 32.7 NS
Total cholesterol [mg/dL] 193.5 ± 44.7 188.3 ± 60.2 NS
Triglycerides [mg/dL] 180.5 ± 68.8 184.2 ± 85.4 NS
HDL [mg/dL] 43.2 ± 12.4 40.8 ± 6.8 0.037
LDL [mg/dL] 121.1 ± 41.3 116.3 ± 32.0 NS
hsCRP [mg/L] 28.5 ± 43.8 54.2 ± 74.4 < 0.01
Glycated hemoglobin (%) 6.2 ± 1.3 6.4 ± 0.4 NS
NT-proBNP [pg/mL] 524.0 ± 233.1 2314.1 ± 1381.7 < 0.01
Testosterone [ng/mL] 4.3 ± 3.3 2.1 ± 0.8 0.031
LVEF (%) 37.4 ± 9.8 32.6 ± 11.5 < 0.01
MI — myocardial infarction; HDL — high-density lipoprotein cholesterol; LDL — low-density lipoprotein cholesterol; hsCRP — high sensitivity
C-reactive protein; NT-proBNP — N-terminal pro-B-type natriuretic peptide; LVEF — left ventricular ejection fraction; NS — not significant
Table 3. Distribution of variables by quartile group of serum testosterone level.
Quartile groups of testosterone
1 2 3 4
Age (years) 62.7 ± 10.9 61.7 ± 9.6 61.4 ± 11.6 60.3 ± 10.8 0.06
ST segment elevation MI (%) 42.2 40.4 41.6 39.4 0.08
Arterial hypertension (%) 69.4 68.2 69.3 70.1 0.2
Diabetes mellitus (%) 34.5 32.5 32.1 30.5 0.004
Smokers (%) 65.2 65.5 67.1 60.2 0.09
Body mass index [kg/m2] 29.1 ± 6.7 27.7 ± 4.3 27.1 ± 3.2 25.4 ± 4.8 0.002
Baseline glycemia [mg/dL] 116.2 ± 32.7 113.7 ± 24.6 114.7 ± 45.8 115.1 ± 21.1 0.3
Total cholesterol [mg/dL] 193.8 ± 42.2 190.2 ± 30.2 187.4 ± 25.4 187.3 ± 32.6 0.003
Triglycerides [mg/dL] 186.3 ± 65.1 183.8 ± 43.6 180.8 ± 35.2 178.4 ± 29.1 0.004
HDL [mg/dL] 38.3 ± 12.2 38.9 ± 10.3 36.6 ± 14.6 35.2 ± 9.8 < 0.001
LDL [mg/dL] 115.6 ± 27.4 117.4 ± 30.2 117.9 ± 23.5 119.6 ± 34.1 < 0.001
hsCRP [mg/L] 33.2 ± 17.4 31.1 ± 23.1 29.5 ± 15.3 27.3 ± 8.9 < 0.001
Glycated hemoglobin (%) 6.3 ± 2.1 6.1 ± 0.9 6.2 ± 0.4 5.9 ± 0.9 0.4
NT-proBNP [pg/mL] 1814.0 ± 745.1 1809.2 ± 423.5 1832.2 ± 632.2 1756.5 ± 562.9 0.03
LVEF (%) 33.2 ± 9.3 34.7 ± 11.2 35.7 ± 6.8 35.9 ± 7.8 0.06
MI — myocardial infarction; HDL — high-density lipoprotein cholesterol; LDL — low-density lipoprotein cholesterol; hsCRP — high sensitivity C-reactive
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group of testosterone, and strengthened slightly
after multivariable adjustment for covariates. For
total mortality, the odds ratio (95% confidence in-
tervals) for increasing quartiles of endogenous to-
tal testosterone compared with the lowest quartile
were 0.72 (0.51 to 1.00), 0.61 (0.43 to 0.81), and 0.56
(0.40 to 0.83), respectively, after adjustment for age,
body mass index, total cholesterol, LDL and HDL
cholesterol, tryglicerides, cigarette smoking, dia-
betes mellitus, history of hypertension, LVEF,
hsCRP and NT-proBNP levels.
Discussion
Our study shows that men with acute MI and
a low endogenous testosterone level have a higher
risk of short-term (30-day) mortality. Serum test-
osterone was significantly related to mortality, in-
dependent of age, body mass index, lipid profile,
cigarette smoking, diabetes mellitus, history of hy-
pertension, LVEF, hsCRP and NT-proBNP levels.
Considering that, in our study, all non-survi-
vors had T level £ 3 ng/mL, this cut-off value could
be used as a marker of mortality risk in acute myo-
cardial infarction. That remains to be validated with
the further collection of data.
The level of testosterone was inversely relat-
ed to that of hsCRP. We consider this to be an im-
portant finding that needs to be explored in future
studies.
We also found a weak but significant positive
correlation between T level and total serum cho-
lesterol.
Several studies linked hypoandrogenemia with
visceral obesity, insulin resistance, impaired lipid
profile, and coagulation [1–4]. High T levels were
found to be associated with high HDL-cholesterol
levels, low LDL-cholesterol, and low triglyceride
levels [5–7].
More cross-sectional studies have reported an
association between hypotestosteronemia and car-
diovascular morbidity [8, 9]. Several studies report
that male survivors of MI have lower T levels than
Table 4. Odds ratio (OR) of mortality due to all causes by quartile group of serum testosterone.
           Quartile groups of testosterone
1 2 3 4
Age-adjusted OR 1 0.82 (0.67–1.03) 0.67 (0.52–0.86) 0.70 (0.56–0.89) < 0.01
Age and covariate-adjusted OR 1 0.72 (0.51–1.00) 0.61 (0.43–0.81) 0.56 (0.40–0.83) < 0.01
ORs were estimated with logistic regression. The p values for trend are based on c2 test. Covariates are age, body mass index, LDL and HDL chole-
sterol, tryglicerides, cigarette smoking, diabetes mellitus, history of hypertension, left ventricular ejection fraction, high sensitivity C-reactive protein
and N-terminal pro-B-type natriuretic peptide levels.
controls, while others report an increased oestra-
diol to testosterone ratio which was mainly due to
lower T levels rather than to increased oestrogen
levels. Sewdarsen et al. [8] found significantly low-
er plasma levels of testosterone in men suffering
an acute myocardial infarction.
Other studies suggest that although low T le-
vels are associated with an increase in biochemical
risk factors of cardiovascular disease, they are not
associated with an increased risk of cardiovascu-
lar mortality or morbidity. Several cross-section-
al and prospective studies have found no signifi-
cant relationships between endogenous testoster-
one concentrations and cardiovascular disease
events [10, 11].
In an analysis on the population of the Europe-
an Prospective Investigation Into Cancer in Norfolk
(EPIC-Norfolk) study [12] that included 11,606
men, the authors found that endogenous testoster-
one concentrations are inversely related to mortal-
ity due to cardiovascular disease, and that of all
causes, and that a low testosterone level may be
a predictive marker for cardiovascular disease. The
risk of total mortality was 25% to 30% lower in the
highest compared with the lowest quartile of test-
osterone level, and a 1-SD increase in testosterone
level was associated with a 14% lower risk of total
mortality. Testosterone concentrations were signi-
ficantly associated with several cardiovascular risk
factors (total, LDL and HDL cholesterol, triglyce-
rides, body mass index, and diabetes prevalence).
The effects of exogenous T on cardiovascular
mortality or morbidity have not been extensively
investigated in prospective controlled studies [13].
Conclusions
Low endogenous testosterone level is indepen-
dently associated with a higher short-term mortal-
ity in men with acute myocardial infarction. A se-
rum level of testosterone lower than 3 ng/mL could
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